Biocept, Inc. (BIOCQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Cash Flow | -13.28 Million | 3.69 Million | -19.78 Million | -23.04 Million |
| Net Income | -32.08 Million | -2.82 Million | -17.8 Million | -25.13 Million |
| Depreciation & Amortization | 2.19 Million | 2.63 Million | 1 Million | 773.31 Thousand |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 3.22 Million | 2.46 Million | 941 Thousand | 869.57 Thousand |
| Change in working capital | 13.28 Million | 1.3 Million | -6.26 Million | -1.39 Million |
| Other non-cash items | 38 Thousand | 8.72 Million | 12.84 Million | 6.39 Million |
| Investing Cash Flow | -807 Thousand | -1.57 Million | -866.81 Thousand | -735.3 Thousand |
| Investments in PPE | -807 Thousand | -1.57 Million | -866.81 Thousand | -735.3 Thousand |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | -1.87 Million | 12.37 Million | 25.72 Million | 29.66 Million |
| Debt repayment | -2.11 Million | -1.77 Million | -1.53 Million | -932.87 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 240 Thousand | 14.15 Million | 27.25 Million | 30.59 Million |
| Other Financing Activities | -806 Thousand | -622 Thousand | -833 Thousand | -393.45 Thousand |
| Accounts receivables | 11.63 Million | 358 Thousand | -10.61 Million | -1.95 Million |
| Accounts payables | -5.86 Million | -411 Thousand | 4.46 Million | 14.83 Thousand |
| Inventory | 1.89 Million | -828 Thousand | -1.4 Million | -194.92 Thousand |
| Other working capital | 5.61 Million | 2.18 Million | 1.29 Million | 733.44 Thousand |
| Cash at beginning of period | 28.86 Million | 14.36 Million | 9.3 Million | 3.42 Million |
| Cash at end of period | 12.89 Million | 28.86 Million | 14.36 Million | 9.3 Million |
| Capital Expenditure | -807 Thousand | -1.57 Million | -866.81 Thousand | -735.3 Thousand |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -15.96 Million | 14.49 Million | 5.06 Million | 5.87 Million |
| Free Cash Flow | -14.09 Million | 2.11 Million | -20.65 Million | -23.78 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.63 Million | -7.14 Million | -18.52 Million | -32.08 Million | -10.12 Million | -2.82 Million |
| Depreciation & Amortization | 666 Thousand | 614 Thousand | 438 Thousand | 2.19 Million | 541 Thousand | 2.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 209 Thousand | 316 Thousand | -137 Thousand | 3.22 Million | - | 2.46 Million |
| Change in working capital | 1.69 Million | 20 Thousand | 13.83 Million | 13.28 Million | 9.74 Million | 1.3 Million |
| Other non-cash items | -1.29 Million | 491 Thousand | 141 Thousand | 38 Thousand | -12.78 Million | 8.72 Million |
| Investing Cash Flow | -22 Thousand | -91 Thousand | -136 Thousand | -807 Thousand | -356 Thousand | -1.57 Million |
| Investments in PPE | -97 Thousand | -91 Thousand | -136 Thousand | -807 Thousand | -356 Thousand | -1.57 Million |
| Acquisitions | 75 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.96 Million | 162 Thousand | -746 Thousand | -1.87 Million | -476 Thousand | 12.37 Million |
| Debt repayment | -591 Thousand | -234 Thousand | -59 Thousand | -2.11 Million | -621 Thousand | -1.77 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.55 Million | 396 Thousand | 1000.00 | 240 Thousand | 145 Thousand | 14.15 Million |
| Other Financing Activities | - | - | - | -806 Thousand | - | -622 Thousand |
| Accounts receivables | 312 Thousand | 1.03 Million | 13.61 Million | 11.63 Million | 10.97 Million | 358 Thousand |
| Accounts payables | 347 Thousand | -39 Thousand | -1.3 Million | -5.86 Million | -1.7 Million | -411 Thousand |
| Inventory | 153 Thousand | 53 Thousand | 1.14 Million | 1.89 Million | 352 Thousand | -828 Thousand |
| Other working capital | 882 Thousand | -1.03 Million | - | 5.61 Million | 119 Thousand | 2.18 Million |
| Cash at beginning of period | 6.77 Million | 18.02 Million | 18.02 Million | 28.86 Million | 22.92 Million | 14.36 Million |
| Cash at end of period | 6.63 Million | 6.77 Million | 12.89 Million | 12.89 Million | 18.02 Million | 28.86 Million |
| Capital Expenditure | -97 Thousand | -91 Thousand | -136 Thousand | -807 Thousand | -356 Thousand | -1.57 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -141 Thousand | -11.24 Million | -5.12 Million | -15.96 Million | -4.9 Million | 14.49 Million |
| Free Cash Flow | -3.18 Million | -6.28 Million | -4.37 Million | -14.09 Million | -4.43 Million | 2.11 Million |
ASND
002199
VIZC
AYA
NER
SPNS